DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% (dopamine hydrochloride) by B. Braun is clinical pharmacology dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (dopa). Approved for hemodynamic status in patients in shock. First approved in 1986.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
Dopamine hydrochloride 5% in dextrose is an intravenous catecholamine agonist indicated for hemodynamic support in patients experiencing shock. The drug works by activating dopamine, beta-1, and alpha-1 receptors in a dose-dependent manner, producing positive chronotropic and inotropic effects on cardiac contractility while promoting peripheral vasodilation at lower doses. It is rapidly metabolized with a plasma half-life of approximately two minutes.
This 1986-approved product is in late-stage lifecycle with LOE approaching, suggesting smaller brand teams focused on managed decline and generic transition planning rather than growth initiatives.
CLINICAL PHARMACOLOGY Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal…
Worked on DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% at B. Braun? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on dopamine HCl offers stability in a critical-care staple but limited advancement potential given LOE approaching status and generic competition. Roles emphasize operational excellence, hospital relationships, and compliance rather than brand building or innovation.